Citigroup’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-92,900
Closed -$3.32M 6380
2022
Q2
$3.32M Buy
92,900
+69,300
+294% +$2.8M ﹤0.01% 1762
2022
Q1
$1.16M Buy
+23,600
New +$1.25M ﹤0.01% 2820
2021
Q1
Sell
-2,500
Closed -$131K 7538
2020
Q4
$131K Sell
2,500
-1,200
-32% -$59.2K ﹤0.01% 5319
2020
Q3
$162K Buy
3,700
+2,800
+311% +$124K ﹤0.01% 4768
2020
Q2
$40K Buy
+900
New +$38.1K ﹤0.01% 6160
2020
Q1
Sell
-39,400
Closed -$2.23M 7795
2019
Q4
$2.23M Buy
39,400
+36,000
+1,059% +$2.01M ﹤0.01% 2854
2019
Q3
$181K Sell
3,400
-3,200
-48% -$172K ﹤0.01% 5234
2019
Q2
$385K Buy
+6,600
New +$355K ﹤0.01% 4679

Other funds holding XRAY

Citigroup's XRAY Position: Q1 2026 in Review

Citigroup reduced its Dentsply Sirona (XRAY) stake by 45% in Q1 2026, selling an estimated $2.37M and leaving 230,299 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2481.

Citigroup first reported a position in XRAY in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.6M in Q1 2020. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Citigroup held 230,299 shares of Dentsply Sirona worth $2.67M as of Q1 2026.
  • Citigroup sold 190,034 Dentsply Sirona shares in Q1 2026, an estimated $2.37M.
  • Dentsply Sirona made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2481 holding.
  • Citigroup first reported a position in Dentsply Sirona in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Dentsply Sirona position peaked at $18.6M in Q1 2020.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.